What does the VLDL Cholesterol (Very Low-Density Lipoprotein Cholesterol) test measure?

Why is VLDL Cholesterol (Very Low-Density Lipoprotein Cholesterol) measured?

VLDL-C as a discrete clinical parameter has limited independent clinical utility in the standard lipid panel beyond its role in the Friedewald LDL-C equation. Elevated VLDL-C above 40 mg/dL reflects hypertriglyceridaemia and increased hepatic VLDL output — typically driven by insulin resistance, caloric excess, alcohol, or genetic dyslipidaemia. In the broader cardiovascular risk context, VLDL remnant particles (IDL) are directly atherogenic independently of LDL; the remnant cholesterol concept — calculating remnant cholesterol as non-HDL-C minus LDL-C — captures the VLDL and IDL atherogenic contribution beyond LDL-C and is gaining traction as a clinical risk marker in metabolic syndrome.

Reference ranges

Standard reference

5–40 mg/dL (0.13–1.04 mmol/L) # REVIEWER FLAG: Confirm whether VLDL-C is reported as a standard component of the LabCorp Lipid Panel — VLDL-C is typically a derived value (TG ÷ 5 by the Friedewald assumption) and may or may not be explicitly reported depending on LabCorp's panel configuration. Confirm whether VLDL is reported as a discrete value or only implicitly reflected in the LDL-C calculation.

Functional medicine optimal

<20 mg/dL (functional preventive cardiology target corresponding to triglycerides <100 mg/dL with normal Friedewald TG:VLDL ratio). # REVIEWER FLAG: VLDL-C optimal range is not standardised in mainstream guidelines — reviewer to confirm framing.

Units

mg/dL, mmol/L

Reference ranges vary by laboratory and assay platform. Interpret in context of the issuing laboratory's stated range.